{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:11:00Z","timestamp":1790093460990,"version":"4.0.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1051500"],"award-info":[{"award-number":["APP1051500"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1051500"],"award-info":[{"award-number":["APP1051500"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1051500"],"award-info":[{"award-number":["APP1051500"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1051500"],"award-info":[{"award-number":["APP1051500"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1051500"],"award-info":[{"award-number":["APP1051500"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1051500"],"award-info":[{"award-number":["APP1051500"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1051500"],"award-info":[{"award-number":["APP1051500"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stroke is a leading cause of mortality and morbidity with a paucity of effective pharmacological treatments. We have previously identified insulin-regulated aminopeptidase (IRAP) as a potential target for the development of a new class of drugs for the treatment of stroke, as global deletion of this gene in mice significantly protected against ischemic damage. In the current study, we demonstrate that small molecular weight IRAP inhibitors reduce infarct volume and improve neurological outcome in a hypertensive animal model of ischemic stroke. The effects of two structurally distinct IRAP inhibitors (HFI419 or SJM164) were investigated in a model of stroke where the middle cerebral artery was transiently occluded with endothelin-1 in the conscious spontaneously hypertensive rat. IRAP inhibitor was administered into the lateral ventricle at 2 or 6\u00a0h after stroke, with subsequent doses delivered at 24, 48 and 70\u00a0h post-stroke. Functional outcomes were assessed prior to drug treatment, and on day 1 and 3 post-stroke. Histological analyses and neuroinflammatory cytokine profiling were conducted at 72 and 24\u00a0h post-stroke respectively. IRAP inhibitor treatment following stroke significantly reduced infarct volume and improved neurological and motor deficits. These protective effects were maintained even when the therapeutic window was extended to 6\u00a0h. Examination of the cellular architecture at 72\u00a0h post-stroke demonstrated that IRAP expression was upregulated in CD11b positive cells and activated astrocytes. Furthermore, IRAP inhibitor treatment significantly increased gene expression for interleukin 6 and C\u2013C motif chemokine ligand 2 in the ischemic core. This study provides proof-of-principle that selective inhibition of IRAP activity with two structurally distinct IRAP inhibitors reduces infarct volume and improves functional outcome even when the first dose is administered 6 h post-stroke. This is the first direct evidence that IRAP inhibitors are a class of drug with potential use in the treatment of ischemic stroke.<\/jats:p>","DOI":"10.1038\/s41598-023-46072-5","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T11:01:44Z","timestamp":1699873304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inhibition of insulin-regulated aminopeptidase confers\u00a0neuroprotection\u00a0in a conscious model of ischemic\u00a0stroke"],"prefix":"10.1038","volume":"13","author":[{"given":"Jonathon","family":"Telianidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Widdop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kemp-Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vi","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Yeen","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"46072_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/CIRCRESAHA.116.308413","volume":"120","author":"VL Feigin","year":"2017","unstructured":"Feigin, V. L., Norrving, B. & Mensah, G. A. Global burden of stroke. Circ. Res. 120, 439\u2013448. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308413 (2017).","journal-title":"Circ. Res."},{"key":"46072_CR2","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson, J. et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials. Lancet 384, 1929\u20131935. https:\/\/doi.org\/10.1016\/S0140-6736(14)60584-5 (2014).","journal-title":"Lancet"},{"key":"46072_CR3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke, W. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317\u20131329. https:\/\/doi.org\/10.1056\/NEJMoa0804656 (2008).","journal-title":"N. Engl. J. Med."},{"key":"46072_CR4","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1056\/NEJMoa1813046","volume":"380","author":"H Ma","year":"2019","unstructured":"Ma, H. et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N. Engl. J. Med. 380, 1795\u20131803. https:\/\/doi.org\/10.1056\/NEJMoa1813046 (2019).","journal-title":"N. Engl. J. Med."},{"key":"46072_CR5","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","volume":"372","author":"JL Saver","year":"2015","unstructured":"Saver, J. L. et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N. Engl. J. Med. 372, 2285\u20132295. https:\/\/doi.org\/10.1056\/NEJMoa1415061 (2015).","journal-title":"N. Engl. J. Med."},{"key":"46072_CR6","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","volume":"372","author":"TG Jovin","year":"2015","unstructured":"Jovin, T. G. et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N. Engl. J. Med. 372, 2296\u20132306. https:\/\/doi.org\/10.1056\/NEJMoa1503780 (2015).","journal-title":"N. Engl. J. Med."},{"key":"46072_CR7","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","volume":"372","author":"M Goyal","year":"2015","unstructured":"Goyal, M. et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N. Engl. J. Med. 372, 1019\u20131030. https:\/\/doi.org\/10.1056\/NEJMoa1414905 (2015).","journal-title":"N. Engl. J. Med."},{"key":"46072_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","volume":"372","author":"BCV Campbell","year":"2015","unstructured":"Campbell, B. C. V. et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N. Engl. J. Med. 372, 1009\u20131018. https:\/\/doi.org\/10.1056\/NEJMoa1414792 (2015).","journal-title":"N. Engl. J. Med."},{"key":"46072_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","volume":"372","author":"OA Berkhemer","year":"2015","unstructured":"Berkhemer, O. A. et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Engl. J. Med. 372, 11\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1411587 (2015).","journal-title":"N. Engl. J. Med."},{"key":"46072_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2014.09.003","volume":"146","author":"A Moretti","year":"2015","unstructured":"Moretti, A., Ferrari, F. & Villa, R. F. Neuroprotection for ischaemic stroke: Current status and challenges. Pharmacol. Ther. 146, 23\u201334. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.09.003 (2015).","journal-title":"Pharmacol. Ther."},{"key":"46072_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1089\/neu.2011.1824","volume":"29","author":"V Pham","year":"2012","unstructured":"Pham, V. et al. Insulin-regulated aminopeptidase deficiency provides protection against ischemic stroke in mice. J. Neurotrauma 29, 1243\u20131248. https:\/\/doi.org\/10.1089\/neu.2011.1824 (2012).","journal-title":"J. Neurotrauma"},{"key":"46072_CR12","doi-asserted-by":"publisher","first-page":"23612","DOI":"10.1074\/jbc.270.40.23612","volume":"270","author":"SR Keller","year":"1995","unstructured":"Keller, S. R., Scott, H. M., Mastick, C. C., Aebersold, R. & Lienhard, G. E. Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles (\u2217). J. Biol. Chem. 270, 23612\u201323618. https:\/\/doi.org\/10.1074\/jbc.270.40.23612 (1995).","journal-title":"J. Biol. Chem."},{"key":"46072_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/cne.20585","volume":"487","author":"RN Fernando","year":"2005","unstructured":"Fernando, R. N., Larm, J., Albiston, A. L. & Chai, S. Y. Distribution and cellular localization of insulin-regulated aminopeptidase in the rat central nervous system. J. Comp. Neurol. 487, 372\u2013390. https:\/\/doi.org\/10.1002\/cne.20585 (2005).","journal-title":"J. Comp. Neurol."},{"key":"46072_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/1470320313507621","volume":"15","author":"A Nikolaou","year":"2014","unstructured":"Nikolaou, A. et al. Presence and regulation of insulin-regulated aminopeptidase in mouse macrophages. J. Renin-Angiotensin-Aldosterone Syst. 15, 466\u2013479. https:\/\/doi.org\/10.1177\/1470320313507621 (2014).","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"46072_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-0854.2006.00373.x","volume":"7","author":"H Liao","year":"2006","unstructured":"Liao, H., Keller, S. R. & Castle, J. D. Insulin-regulated aminopeptidase marks an antigen-stimulated recycling compartment in mast cells. Traffic 7, 155\u2013167. https:\/\/doi.org\/10.1111\/j.1600-0854.2006.00373.x (2006).","journal-title":"Traffic"},{"key":"46072_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1126\/science.1172845","volume":"325","author":"L Saveanu","year":"2009","unstructured":"Saveanu, L. et al. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science 325, 213\u2013217. https:\/\/doi.org\/10.1126\/science.1172845 (2009).","journal-title":"Science"},{"key":"46072_CR17","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1091\/mbc.e10-02-0158","volume":"21","author":"I Jordens","year":"2010","unstructured":"Jordens, I., Molle, D., Xiong, W., Keller, S. R. & McGraw, T. E. Insulin-regulated aminopeptidase is a key regulator of GLUT4 trafficking by controlling the sorting of GLUT4 from endosomes to specialized insulin-regulated vesicles. Mol. Biol. Cell 21, 2034\u20132044. https:\/\/doi.org\/10.1091\/mbc.e10-02-0158 (2010).","journal-title":"Mol. Biol. Cell"},{"key":"46072_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1091\/mbc.12.2.367","volume":"12","author":"AO Johnson","year":"2001","unstructured":"Johnson, A. O., Lampson, M. A. & McGraw, T. E. A di-leucine sequence and a cluster of acidic amino acids are required for dynamic retention in the endosomal recycling compartment of fibroblasts. Mol. Biol. Cell 12, 367\u2013381. https:\/\/doi.org\/10.1091\/mbc.12.2.367 (2001).","journal-title":"Mol. Biol. Cell"},{"key":"46072_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1046\/j.1471-4159.2003.01852.x","volume":"86","author":"RA Lew","year":"2003","unstructured":"Lew, R. A. et al. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J. Neurochem. 86, 344\u2013350. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01852.x (2003).","journal-title":"J. Neurochem."},{"key":"46072_CR20","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1046\/j.1432-1327.2001.02221.x","volume":"268","author":"H Matsumoto","year":"2001","unstructured":"Matsumoto, H. et al. Expression of placental leucine aminopeptidase\/oxytocinase in neuronal cells and its action on neuronal peptides. Eur. J. Biochem. 268, 3259\u20133266. https:\/\/doi.org\/10.1046\/j.1432-1327.2001.02221.x (2001).","journal-title":"Eur. J. Biochem."},{"key":"46072_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0361-9230(93)90297-o","volume":"32","author":"JW Wright","year":"1993","unstructured":"Wright, J. W. et al. Angiotensin II(3\u20138) (ANG IV) hippocampal binding: Potential role in the facilitation of memory. Brain Res. Bull. 32, 497\u2013502. https:\/\/doi.org\/10.1016\/0361-9230(93)90297-o (1993).","journal-title":"Brain Res. Bull."},{"key":"46072_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/0306-4522(88)90182-0","volume":"27","author":"JJ Braszko","year":"1988","unstructured":"Braszko, J. J., Kupryszewski, G., Witczuk, B. & Wi\u015bniewski, K. Angiotensin II-(3\u20138)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 27, 777\u2013783. https:\/\/doi.org\/10.1016\/0306-4522(88)90182-0 (1988).","journal-title":"Neuroscience"},{"key":"46072_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuroscience.2003.12.006","volume":"124","author":"J Lee","year":"2004","unstructured":"Lee, J. et al. Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats. Neuroscience 124, 341\u2013349. https:\/\/doi.org\/10.1016\/j.neuroscience.2003.12.006 (2004).","journal-title":"Neuroscience"},{"key":"46072_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(95)01454-3","volume":"717","author":"JW Wright","year":"1996","unstructured":"Wright, J. W. et al. Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. Brain Res. 717, 1\u201311. https:\/\/doi.org\/10.1016\/0006-8993(95)01454-3 (1996).","journal-title":"Brain Res."},{"key":"46072_CR25","doi-asserted-by":"publisher","first-page":"104644","DOI":"10.1016\/j.nbd.2019.104644","volume":"134","author":"J Royea","year":"2020","unstructured":"Royea, J., Martinot, P. & Hamel, E. Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 134, 104644. https:\/\/doi.org\/10.1016\/j.nbd.2019.104644 (2020).","journal-title":"Neurobiol. Dis."},{"key":"46072_CR26","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1523\/JNEUROSCI.19-10-03952.1999","volume":"19","author":"JW Wright","year":"1999","unstructured":"Wright, J. W. et al. Contributions of the brain angiotensin IV\u2013AT<sub>4<\/sub> receptor subtype system to spatial learning. J. Neurosci. 19, 3952. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-10-03952.1999 (1999).","journal-title":"J. Neurosci."},{"key":"46072_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bbr.2004.02.012","volume":"154","author":"AL Albiston","year":"2004","unstructured":"Albiston, A. L. et al. Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms. Behav. Brain Res. 154, 239\u2013243. https:\/\/doi.org\/10.1016\/j.bbr.2004.02.012 (2004).","journal-title":"Behav. Brain Res."},{"key":"46072_CR28","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1096\/fj.08-112227","volume":"22","author":"A Albiston","year":"2008","unstructured":"Albiston, A. et al. Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 22, 4209\u20134217. https:\/\/doi.org\/10.1096\/fj.08-112227 (2008).","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"46072_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/jnc.14880","volume":"153","author":"B Seyer","year":"2020","unstructured":"Seyer, B. et al. Insulin-regulated aminopeptidase inhibitor-mediated increases in dendritic spine density are facilitated by glucose uptake. J. Neurochem. 153, 485\u2013494. https:\/\/doi.org\/10.1111\/jnc.14880 (2020).","journal-title":"J. Neurochem."},{"key":"46072_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.seizure.2011.04.015","volume":"20","author":"E Loyens","year":"2011","unstructured":"Loyens, E. et al. Deletion of insulin-regulated aminopeptidase in mice decreases susceptibility to pentylenetetrazol-induced generalized seizures. Seizure\u2014Eur. J. Epilepsy 20, 602\u2013605. https:\/\/doi.org\/10.1016\/j.seizure.2011.04.015 (2011).","journal-title":"Seizure\u2014Eur. J. Epilepsy"},{"key":"46072_CR31","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/01.STR.31.6.1223","volume":"31","author":"P Langhorne","year":"2000","unstructured":"Langhorne, P. et al. Medical complications after stroke. Stroke 31, 1223\u20131229. https:\/\/doi.org\/10.1161\/01.STR.31.6.1223 (2000).","journal-title":"Stroke"},{"key":"46072_CR32","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie Du Sert","year":"2020","unstructured":"Percie Du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biology 18, e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411 (2020).","journal-title":"PLOS Biology"},{"key":"46072_CR33","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1161\/HYPERTENSIONAHA.112.199646","volume":"60","author":"C McCarthy","year":"2012","unstructured":"McCarthy, C. et al. Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats. Hypertension 60, 1531\u20131537. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.199646 (2012).","journal-title":"Hypertension"},{"key":"46072_CR34","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1161\/STROKEAHA.108.531509","volume":"40","author":"C McCarthy","year":"2009","unstructured":"McCarthy, C., Vinh, A., Callaway, J. & Widdop, R. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke J. Cereb. Circ. 40, 1482\u20131489. https:\/\/doi.org\/10.1161\/STROKEAHA.108.531509 (2009).","journal-title":"Stroke J. Cereb. Circ."},{"key":"46072_CR35","doi-asserted-by":"publisher","first-page":"e95762","DOI":"10.1371\/journal.pone.0095762","volume":"9","author":"CA McCarthy","year":"2014","unstructured":"McCarthy, C. A. et al. Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats. PloS one 9, e95762. https:\/\/doi.org\/10.1371\/journal.pone.0095762 (2014).","journal-title":"PloS one"},{"key":"46072_CR36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejphar.2008.01.046","volume":"584","author":"CL Roulston","year":"2008","unstructured":"Roulston, C. L., Callaway, J. K., Jarrott, B., Woodman, O. L. & Dusting, G. J. Using behaviour to predict stroke severity in conscious rats: Post-stroke treatment with 3\u2032, 4\u2032-dihydroxyflavonol improves recovery. Eur. J. Pharmacol. 584, 100\u2013110. https:\/\/doi.org\/10.1016\/j.ejphar.2008.01.046 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"46072_CR37","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1113\/expphysiol.2009.047936","volume":"94","author":"A Mecca","year":"2009","unstructured":"Mecca, A., O\u2019Connor, T., Katovich, M. & Sumners, C. Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion. Exp. Physiol. 94, 937\u2013946. https:\/\/doi.org\/10.1113\/expphysiol.2009.047936 (2009).","journal-title":"Exp. Physiol."},{"key":"46072_CR38","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","volume":"96","author":"A Mecca","year":"2011","unstructured":"Mecca, A. et al. Cerebroprotection by angiotensin-(1\u20137) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 96, 1084\u20131096. https:\/\/doi.org\/10.1113\/expphysiol.2011.058578 (2011).","journal-title":"Exp. Physiol."},{"key":"46072_CR39","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/01.STR.20.10.1383","volume":"20","author":"M De Ryck","year":"1989","unstructured":"De Ryck, M., Van Reempts, J., Borgers, M., Wauquier, A. & Janssen, P. A. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke J. Cereb. Circ. 20, 1383\u20131390. https:\/\/doi.org\/10.1161\/01.STR.20.10.1383 (1989).","journal-title":"Stroke J. Cereb. Circ."},{"key":"46072_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0006-8993(88)90036-4","volume":"452","author":"M Yamamoto","year":"1988","unstructured":"Yamamoto, M., Tamura, A., Kirino, T., Shimizu, M. & Sano, K. Behavioral changes after focal cerebral ischemia by left middle cerebral artery occlusion in rats. Brain Res. 452, 323\u2013328. https:\/\/doi.org\/10.1016\/0006-8993(88)90036-4 (1988).","journal-title":"Brain Res."},{"key":"46072_CR41","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/00004647-199810000-00006","volume":"18","author":"F Yonemori","year":"1998","unstructured":"Yonemori, F., Yamaguchi, T., Yamada, H. & Tamura, A. Evaluation of a motor deficit after chronic focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 18, 1099\u20131106 (1998).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"46072_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0165-0270(00)00278-8","volume":"102","author":"J Callaway","year":"2000","unstructured":"Callaway, J. et al. A novel, rapid, computerized method for quantitation of neuronal damage in a rat model of stroke. J. Neurosci. Methods 102, 53\u201360. https:\/\/doi.org\/10.1016\/S0165-0270(00)00278-8 (2000).","journal-title":"J. Neurosci. Methods"},{"key":"46072_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/jnnp.50.4.402","volume":"50","author":"KA Osborne","year":"1987","unstructured":"Osborne, K. A. et al. Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J. Neurol. Neurosurg. Psychiatry 50, 402\u2013410 (1987).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"46072_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif.) 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods (San Diego, Calif.)"},{"key":"46072_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1152\/ajpendo.00440.2007","volume":"293","author":"M Wallis","year":"2007","unstructured":"Wallis, M., Lankford, M. & Keller, S. Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. Am. J. Physiol. Endocrinol. Metab. 293, 102. https:\/\/doi.org\/10.1152\/ajpendo.00440.2007 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"46072_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/bs.vh.2019.08.015","volume":"113","author":"E Zeynalov","year":"2020","unstructured":"Zeynalov, E., Jones, S. M. & Elliott, J. P. Vasopressin and vasopressin receptors in brain edema. Vitam. Horm. 113, 291\u2013312. https:\/\/doi.org\/10.1016\/bs.vh.2019.08.015 (2020).","journal-title":"Vitam. Horm."},{"key":"46072_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1747-4949.2012.00770.x","volume":"7","author":"BA Sutherland","year":"2012","unstructured":"Sutherland, B. A. et al. Neuroprotection for ischaemic stroke: Translation from the bench to the bedside. Int. J. Stroke 7, 407\u2013418. https:\/\/doi.org\/10.1111\/j.1747-4949.2012.00770.x (2012).","journal-title":"Int. J. Stroke"},{"key":"46072_CR48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ana.20741","volume":"59","author":"V O'Collins","year":"2006","unstructured":"O\u2019Collins, V. et al. 1026 experimental treatments in acute stroke. Ann. Neurol. 59, 467\u2013477. https:\/\/doi.org\/10.1002\/ana.20741 (2006).","journal-title":"Ann. Neurol."},{"key":"46072_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1476-5381.2011.01402.x","volume":"164","author":"AL Albiston","year":"2011","unstructured":"Albiston, A. L. et al. Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers. Br. J. Pharmacol. 164, 37\u201347 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"46072_CR50","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1212\/WNL.47.4.884","volume":"47","author":"M Fisher","year":"1996","unstructured":"Fisher, M. & Garcia, J. H. Evolving stroke and the ischemic penumbra. Neurology 47, 884\u2013888. https:\/\/doi.org\/10.1212\/WNL.47.4.884 (1996).","journal-title":"Neurology"},{"key":"46072_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/01.STR.32.1.63","volume":"32","author":"CR Lacy","year":"2001","unstructured":"Lacy, C. R., Suh, D.-C., Bueno, M. & Kostis, J. B. Delay in presentation and evaluation for acute stroke. Stroke 32, 63\u201369. https:\/\/doi.org\/10.1161\/01.STR.32.1.63 (2001).","journal-title":"Stroke"},{"key":"46072_CR52","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3389\/fneur.2017.00617","volume":"8","author":"JN Pulvers","year":"2017","unstructured":"Pulvers, J. N. & Watson, J. D. G. If time is brain where is the improvement in prehospital time after stroke?. Front. Neurol. 8, 617\u2013617. https:\/\/doi.org\/10.3389\/fneur.2017.00617 (2017).","journal-title":"Front. Neurol."},{"key":"46072_CR53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1126\/science.1172845","volume":"325","author":"L Saveanu","year":"2009","unstructured":"Saveanu, L. et al. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science (New York, N.Y.) 325, 213\u2013217. https:\/\/doi.org\/10.1126\/science.1172845 (2009).","journal-title":"Science (New York, N.Y.)"},{"key":"46072_CR54","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1038\/s41467-020-16471-7","volume":"11","author":"I Evnouchidou","year":"2020","unstructured":"Evnouchidou, I. et al. IRAP-dependent endosomal T cell receptor signalling is essential for T cell responses. Nat. Commun. 11, 2779. https:\/\/doi.org\/10.1038\/s41467-020-16471-7 (2020).","journal-title":"Nat. Commun."},{"key":"46072_CR55","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2377-4-2","volume":"4","author":"CJ Smith","year":"2004","unstructured":"Smith, C. J. et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 4, 2. https:\/\/doi.org\/10.1186\/1471-2377-4-2 (2004).","journal-title":"BMC Neurol."},{"key":"46072_CR56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/jcbfm.2008.141","volume":"29","author":"S Suzuki","year":"2008","unstructured":"Suzuki, S., Tanaka, K. & Suzuki, N. Ambivalent aspects of interleukin-6 in cerebral ischemia: Inflammatory versus neurotrophic aspects. J. Cereb. Blood Flow Metab. 29, 464\u2013479. https:\/\/doi.org\/10.1038\/jcbfm.2008.141 (2008).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"46072_CR57","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/00004647-200006000-00008","volume":"20","author":"C Ali","year":"2000","unstructured":"Ali, C. et al. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 20, 956\u2013966. https:\/\/doi.org\/10.1097\/00004647-200006000-00008 (2000).","journal-title":"J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"46072_CR58","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00004647-199802000-00008","volume":"18","author":"SA Loddick","year":"1998","unstructured":"Loddick, S. A., Turnbull, A. V. & Rothwell, N. J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 18, 176\u2013179. https:\/\/doi.org\/10.1097\/00004647-199802000-00008 (1998).","journal-title":"J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"46072_CR59","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1471-4159.2005.03227.x","volume":"94","author":"T Yamashita","year":"2005","unstructured":"Yamashita, T. et al. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: Possible involvement of Stat3 activation in the protection of neurons. J. Neurochem. 94, 459\u2013468. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03227.x (2005).","journal-title":"J. Neurochem."},{"key":"46072_CR60","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/brain\/aws075","volume":"135","author":"K Gertz","year":"2012","unstructured":"Gertz, K. et al. Essential role of interleukin-6 in post-stroke angiogenesis. Brain 135, 1964\u20131980. https:\/\/doi.org\/10.1093\/brain\/aws075 (2012).","journal-title":"Brain"},{"key":"46072_CR61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuroscience.2015.08.055","volume":"307","author":"C Meng","year":"2015","unstructured":"Meng, C., Zhang, J.-C., Shi, R.-L., Zhang, S.-H. & Yuan, S.-Y. Inhibition of interleukin-6 abolishes the promoting effects of pair housing on post-stroke neurogenesis. Neuroscience 307, 160\u2013170 (2015).","journal-title":"Neuroscience"},{"key":"46072_CR62","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1161\/01.STR.31.7.1715","volume":"31","author":"WM Clark","year":"2000","unstructured":"Clark, W. M. et al. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 31, 1715\u20131720 (2000).","journal-title":"Stroke"},{"key":"46072_CR63","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/01.Wcb.0000055177.50448.Fa","volume":"23","author":"O Herrmann","year":"2003","unstructured":"Herrmann, O. et al. Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J. Cereb. Blood Flow Metab. 23, 406\u2013415. https:\/\/doi.org\/10.1097\/01.Wcb.0000055177.50448.Fa (2003).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"46072_CR64","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): An overview. J. Interferon Cytokine Res. 29, 313 (2009).","journal-title":"J. Interferon Cytokine Res."},{"key":"46072_CR65","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/sj.jcbfm.9600229","volume":"26","author":"OB Dimitrijevic","year":"2006","unstructured":"Dimitrijevic, O. B., Stamatovic, S. M., Keep, R. F. & Andjelkovic, A. V. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 26, 797\u2013810. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600229 (2006).","journal-title":"J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"46072_CR66","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1161\/01.STR.0000259709.16654.8f","volume":"38","author":"OB Dimitrijevic","year":"2007","unstructured":"Dimitrijevic, O. B., Stamatovic, S. M., Keep, R. F. & Andjelkovic, A. V. Absence of the chemokine receptor CCR2 protects against cerebral ischemia\/reperfusion injury in mice. Stroke J. Cereb. Circ. 38, 1345\u20131353. https:\/\/doi.org\/10.1161\/01.STR.0000259709.16654.8f (2007).","journal-title":"Stroke J. Cereb. Circ."},{"key":"46072_CR67","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.7150\/thno.24475","volume":"8","author":"W Fang","year":"2018","unstructured":"Fang, W. et al. CCR2-dependent monocytes\/macrophages exacerbate acute brain injury but promote functional recovery after ischemic stroke in mice. Theranostics 8, 3530\u20133543. https:\/\/doi.org\/10.7150\/thno.24475 (2018).","journal-title":"Theranostics"},{"key":"46072_CR68","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1523\/jneurosci.4317-15.2016","volume":"36","author":"S Wattananit","year":"2016","unstructured":"Wattananit, S. et al. Monocyte-derived macrophages contribute to spontaneous long-term functional recovery after stroke in mice. J. Neurosci. 36, 4182\u20134195. https:\/\/doi.org\/10.1523\/jneurosci.4317-15.2016 (2016).","journal-title":"J. Neurosci."},{"key":"46072_CR69","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009426","author":"HX Chu","year":"2015","unstructured":"Chu, H. X. et al. Evidence that Ly6Chi Monocytes are protective in acute ischemic stroke by promoting M2 macrophage polarization. Stroke https:\/\/doi.org\/10.1161\/STROKEAHA.115.009426 (2015).","journal-title":"Stroke"},{"key":"46072_CR70","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ana.23529","volume":"71","author":"M Gliem","year":"2012","unstructured":"Gliem, M. et al. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann. Neurol. 71, 743\u2013752. https:\/\/doi.org\/10.1002\/ana.23529 (2012).","journal-title":"Ann. Neurol."},{"key":"46072_CR71","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1177\/0271678x20909055","volume":"40","author":"J Pedragosa","year":"2020","unstructured":"Pedragosa, J. et al. CCR2 deficiency in monocytes impairs angiogenesis and functional recovery after ischemic stroke in mice. J. Cereb. Blood Flow Metab. 40, S98-s116. https:\/\/doi.org\/10.1177\/0271678x20909055 (2020).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"46072_CR72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2015.08.010","volume":"53","author":"F Mir\u00f3-Mur","year":"2016","unstructured":"Mir\u00f3-Mur, F. et al. Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation. Brain Behav. Immun. 53, 18\u201333. https:\/\/doi.org\/10.1016\/j.bbi.2015.08.010 (2016).","journal-title":"Brain Behav. Immun."},{"key":"46072_CR73","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/ijms18102135","volume":"18","author":"M Kanazawa","year":"2017","unstructured":"Kanazawa, M., Ninomiya, I., Hatakeyama, M., Takahashi, T. & Shimohata, T. Microglia and monocytes\/macrophages polarization reveal novel therapeutic mechanism against stroke. Int. J. Mol. Sci. 18, 2135. https:\/\/doi.org\/10.3390\/ijms18102135 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"46072_CR74","doi-asserted-by":"publisher","first-page":"5929","DOI":"10.7150\/thno.28029","volume":"8","author":"Y Huang","year":"2018","unstructured":"Huang, Y. et al. Targeted homing of CCR2-overexpressing mesenchymal stromal cells to ischemic brain enhances post-stroke recovery partially through PRDX4-mediated blood-brain barrier preservation. Theranostics 8, 5929\u20135944. https:\/\/doi.org\/10.7150\/thno.28029 (2018).","journal-title":"Theranostics"},{"key":"46072_CR75","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/sj.jcbfm.9600432","volume":"27","author":"YP Yan","year":"2007","unstructured":"Yan, Y. P. et al. Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 27, 1213\u20131224. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600432 (2007).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"46072_CR76","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1161\/STROKEAHA.110.606368","volume":"42","author":"RH Andres","year":"2011","unstructured":"Andres, R. H. et al. The CCR2\/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke J. Cereb. Circ. 42, 2923\u20132931. https:\/\/doi.org\/10.1161\/STROKEAHA.110.606368 (2011).","journal-title":"Stroke J. Cereb. Circ."},{"key":"46072_CR77","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/156720208784310259","volume":"5","author":"L Jiang","year":"2008","unstructured":"Jiang, L. et al. MIP-1\u03b1 and MCP-1 induce migration of human umbilical cord blood cells in models of stroke. Curr. Neurovasc. Res. 5, 118\u2013124. https:\/\/doi.org\/10.2174\/156720208784310259 (2008).","journal-title":"Curr. Neurovasc. Res."},{"key":"46072_CR78","first-page":"15","volume":"78","author":"S Chai","year":"2001","unstructured":"Chai, S. et al. Angiotensin AT4 receptor distribution in mouse brain and its possible role in facilitation of spatial memory. J. Neurochem. 78, 15 (2001).","journal-title":"J. Neurochem."},{"key":"46072_CR79","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nlm.2016.09.017","volume":"136","author":"HR Yeatman","year":"2016","unstructured":"Yeatman, H. R., Albiston, A. L., Burns, P. & Chai, S. Y. Forebrain neurone-specific deletion of insulin-regulated aminopeptidase causes age related deficits in memory. Neurobiol. Learn. Mem. 136, 174\u2013182. https:\/\/doi.org\/10.1016\/j.nlm.2016.09.017 (2016).","journal-title":"Neurobiol. Learn. Mem."},{"key":"46072_CR80","first-page":"329","volume":"57","author":"S Faure","year":"2006","unstructured":"Faure, S. et al. Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors. J. Physiol. Pharmacol.: Off. J. Pol. Physiol. Soc. 57, 329\u2013342 (2006).","journal-title":"J. Physiol. Pharmacol.: Off. J. Pol. Physiol. Soc."},{"key":"46072_CR81","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1152\/ajpcell.1998.275.2.C590","volume":"275","author":"J Patel","year":"1998","unstructured":"Patel, J. et al. Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation. Am. J. Physiol. 275, 8 (1998).","journal-title":"Am. J. Physiol."},{"key":"46072_CR82","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0196-9781(97)00291-X","volume":"19","author":"J Coleman","year":"1998","unstructured":"Coleman, J. et al. Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats. Peptides 19, 269\u2013277. https:\/\/doi.org\/10.1016\/S0196-9781(97)00291-X (1998).","journal-title":"Peptides"},{"key":"46072_CR83","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0378-5955(98)00038-0","volume":"119","author":"J Coleman","year":"1998","unstructured":"Coleman, J., Lee, J., Miller, J. & Nuttall, A. Changes in cochlear blood flow due to intra-arterial infusions of angiotensin II (3\u20138) (angiotensin IV) in guinea pigs. Hear. Res. 119, 61\u201368. https:\/\/doi.org\/10.1016\/S0378-5955(98)00038-0 (1998).","journal-title":"Hear. Res."},{"key":"46072_CR84","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0167-0115(98)00039-1","volume":"74","author":"E Kram\u00e1r","year":"1998","unstructured":"Kram\u00e1r, E., Krishnan, R., Harding, J. & Wright, J. Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow. Regul. Pept. 74, 185\u2013192. https:\/\/doi.org\/10.1016\/S0167-0115(98)00039-1 (1998).","journal-title":"Regul. Pept."},{"key":"46072_CR85","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2174\/0929866043406643","volume":"11","author":"AL Albiston","year":"2004","unstructured":"Albiston, A. L., Ye, S. & Chai, S. Y. Membrane bound members of the M1 family: More than aminopeptidases. Protein Pept. Lett. 11, 491\u2013500 (2004).","journal-title":"Protein Pept. Lett."},{"key":"46072_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biopha.2016.11.142","volume":"86","author":"A El-Hawli","year":"2017","unstructured":"El-Hawli, A. et al. IRAP inhibition using HFI419 prevents moderate to severe acetylcholine mediated vasoconstriction in a rabbit model. Biomed. Pharmacother. 86, 23\u201326. https:\/\/doi.org\/10.1016\/j.biopha.2016.11.142 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"46072_CR87","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/cvr\/cvm021","volume":"77","author":"A Vinh","year":"2008","unstructured":"Vinh, A., Widdop, R., Drummond, G. & Gaspari, T. Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice. Cardiovasc. Res. 77, 178\u2013187. https:\/\/doi.org\/10.1093\/cvr\/cvm021 (2008).","journal-title":"Cardiovasc. Res."},{"key":"46072_CR88","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0361-9230(01)00568-8","volume":"56","author":"J Tchekalarova","year":"2001","unstructured":"Tchekalarova, J., Kambourova, T. & Georgiev, V. Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): Interaction with adenosine A(1) receptors. Brain Res. Bull. 56, 87\u201391. https:\/\/doi.org\/10.1016\/s0361-9230(01)00568-8 (2001).","journal-title":"Brain Res. Bull."},{"key":"46072_CR89","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/sj.jcbfm.9600410","volume":"27","author":"H Kitano","year":"2007","unstructured":"Kitano, H., Kirsch, J. R., Hurn, P. D. & Murphy, S. J. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J. Cereb. Blood Flow Metab. 27, 1108\u20131128. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600410 (2007).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"46072_CR90","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1021\/jm401540f","volume":"57","author":"SJ Mountford","year":"2014","unstructured":"Mountford, S. J. et al. Synthesis, structure\u2013activity relationships and brain uptake of a novel series of benzopyran inhibitors of insulin-regulated aminopeptidase. J. Med. Chem. 57, 1368\u20131377 (2014).","journal-title":"J. Med. Chem."},{"key":"46072_CR91","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","volume":"42","author":"Y Yang","year":"2011","unstructured":"Yang, Y. & Rosenberg, G. A. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke J. Cereb. Circ. 42, 3323\u20133328. https:\/\/doi.org\/10.1161\/STROKEAHA.110.608257 (2011).","journal-title":"Stroke J. Cereb. Circ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46072-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46072-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T11:03:03Z","timestamp":1699873383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46072-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46072"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46072-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"12 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19722"}}